Pneumococcal Vaccine Study

Pneumococcal disease is a leading cause of serious illness among children, the elderly and people with underlying medical conditions worldwide, even though there are a number of different vaccines available. That’s why it is important to develop new and more effective vaccines.

‍

We’re looking for people aged 50 – 64 years old and in good health to take part in the Pneumococcal Vaccine Study. This study is testing a potential new pneumococcal vaccine that may provide broader protection than existing pneumococcal vaccines. By taking part in this study, you could contribute to health outcomes globally.

‍

There are no overnight stays required for this study.